Richard Pzena's PFE Position Overview
Richard Pzena (via Pzena Investment Management LLC) currently holds 6.62 M shares of Pfizer Inc. (PFE) worth $168.57 M, representing 0.54% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 44 quarters.
Based on 13F filings since 2013, Richard Pzena has maintained a long-term strategic position in PFE, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2024, adding 4.95 M shares. Largest reduction occurred in Q1 2022, reducing 1.6 M shares.
Analysis based on 13F filings available since 2013 Q2
Richard Pzena's Pfizer (PFE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pfizer (PFE) Trades by Richard Pzena
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2014 | +2.17 M | New Buy | 2.17 M | $31.15 |
| Q1 2015 | -10,950 | Reduce 0.50% | 2.16 M | $34.79 |
| Q2 2015 | +200 | Add 0.01% | 2.16 M | $33.53 |
| Q4 2015 | +1,775 | Add 0.08% | 2.16 M | $32.28 |
| Q1 2016 | +25,511 | Add 1.18% | 2.19 M | $29.64 |
| Q2 2016 | -700 | Reduce 0.03% | 2.19 M | $35.21 |
| Q3 2016 | +143,232 | Add 6.55% | 2.33 M | $33.87 |
| Q4 2016 | -112,127 | Reduce 4.81% | 2.22 M | $32.48 |
| Q2 2017 | +114,765 | Add 5.18% | 2.33 M | $33.59 |
| Q3 2017 | +1.68 M | Add 71.86% | 4.01 M | $35.70 |
| Q4 2017 | +352,869 | Add 8.80% | 4.36 M | $36.22 |
| Q1 2018 | +6,350 | Add 0.15% | 4.37 M | $35.49 |
| Q2 2018 | +89,174 | Add 2.04% | 4.46 M | $36.28 |
| Q3 2018 | -18,237 | Reduce 0.41% | 4.44 M | $44.07 |
| Q4 2018 | -742,393 | Reduce 16.73% | 3.7 M | $43.65 |
| Q1 2019 | -502,831 | Reduce 13.60% | 3.19 M | $42.47 |
| Q2 2019 | -39,262 | Reduce 1.23% | 3.15 M | $43.32 |
| Q3 2019 | -5,815 | Reduce 0.18% | 3.15 M | $35.93 |
| Q4 2019 | +313 | Add 0.01% | 3.15 M | $39.18 |
| Q1 2020 | -340 | Reduce 0.01% | 3.15 M | $32.64 |
| Q2 2020 | -722,584 | Reduce 22.95% | 2.43 M | $32.70 |
| Q3 2020 | +310,417 | Add 12.80% | 2.74 M | $36.70 |
| Q4 2020 | +74,178 | Add 2.71% | 2.81 M | $36.81 |
| Q1 2021 | +89,086 | Add 3.17% | 2.9 M | $36.23 |
| Q2 2021 | +118,931 | Add 4.10% | 3.02 M | $39.16 |
| Q3 2021 | +2 M | Add 66.39% | 5.02 M | $43.01 |
| Q4 2021 | -28,776 | Reduce 0.57% | 4.99 M | $59.05 |
| Q1 2022 | -1.6 M | Reduce 31.96% | 3.4 M | $51.77 |
| Q2 2022 | -427,993 | Reduce 12.60% | 2.97 M | $52.43 |
| Q3 2022 | -100,083 | Reduce 3.37% | 2.87 M | $43.76 |
| Q4 2022 | -109,519 | Reduce 3.82% | 2.76 M | $51.24 |
| Q1 2023 | -17,984 | Reduce 0.65% | 2.74 M | $40.80 |
| Q2 2023 | -17,238 | Reduce 0.63% | 2.72 M | $36.68 |
| Q3 2023 | -5,481 | Reduce 0.20% | 2.72 M | $33.17 |
| Q4 2023 | +4,315 | Add 0.16% | 2.72 M | $28.79 |
| Q1 2024 | +4.95 M | Add 181.64% | 7.67 M | $27.75 |
| Q2 2024 | -412,765 | Reduce 5.38% | 7.26 M | $27.98 |
| Q3 2024 | +24,029 | Add 0.33% | 7.28 M | $28.94 |
| Q4 2024 | -330,130 | Reduce 4.53% | 6.95 M | $26.53 |
| Q1 2025 | +107,402 | Add 1.55% | 7.06 M | $25.34 |
| Q2 2025 | -499,867 | Reduce 7.08% | 6.56 M | $24.24 |
| Q3 2025 | +56,484 | Add 0.86% | 6.62 M | $25.48 |
Richard Pzena's Pfizer Investment FAQs
Richard Pzena first purchased Pfizer Inc. (PFE) in Q4 2014, acquiring 2,170,568 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Richard Pzena has held Pfizer Inc. (PFE) for 44 quarters since Q4 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Richard Pzena's largest addition to Pfizer Inc. (PFE) was in Q1 2024, adding 7,670,445 shares worth $212.85 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Richard Pzena's firm, Pzena Investment Management LLC, owns 6,615,598 shares of Pfizer Inc. (PFE), valued at approximately $168.57 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Pfizer Inc. (PFE) represents approximately 0.54% of Richard Pzena's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Richard Pzena's peak holding in Pfizer Inc. (PFE) was 7,670,445 shares, as reported at the end of Q1 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.